Bioadaptives (BDPT) Retained Earnings (2013 - 2026)

Bioadaptives has disclosed Retained Earnings across 13 years of filings, most recently posting -$10.8 million for Q1 2026.

• Retained Earnings for Q1 2026 came in at -$10.8 million, down 15.72% year-over-year; the trailing twelve-month figure through Mar 2026 was -$10.8 million (down 15.72% YoY), and the FY2025 annual result was -$10.7 million, down 17.0% from the prior year.
• Retained Earnings came in at -$10.8 million for Q1 2026 at Bioadaptives, down from -$10.7 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$7.2 million in Q1 2022 to a low of -$10.8 million in Q1 2026.
• The 5-year median for Retained Earnings is -$8.6 million (2024), against an average of -$8.7 million.
• Across the five-year window, Retained Earnings slipped 18.84% in 2022 and declined 6.28% in 2023, its largest moves.
• Bioadaptives' Retained Earnings stood at -$7.6 million in 2022, then retreated by 9.43% to -$8.3 million in 2023, then slipped by 10.88% to -$9.2 million in 2024, then fell by 17.0% to -$10.7 million in 2025, then slipped by 1.04% to -$10.8 million in 2026.
• The last three Retained Earnings figures came in at -$10.8 million (Q1 2026), -$10.7 million (Q4 2025), and -$9.9 million (Q3 2025), per Business Quant data.